Bioventus Inc is a medical technology company that focuses on developing and commercializing innovative solutions for musculoskeletal health
The company offers a range of products that aim to improve patient outcomes for those suffering from conditions like osteoarthritis and other joint-related issues. Bioventus leverages its expertise in regenerative medicine and biologics to provide therapies that promote healing and facilitate recovery, particularly through its advanced orthopedic treatments. Their portfolio includes both surgical and non-surgical options designed to support healthcare providers in delivering effective care to patients while enhancing mobility and quality of life.
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Bioventus posted strong Q4 results, with EPS and revenue surpassing estimates. The company projects 2025 sales of $560M–$570M and adjusted EPS of $0.64–$0.68.
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday. Shares of Blend Labs, Inc. (NASDAQBLND) rose sharply during Friday’s session after the company reported fourth-quarter financial results.
